Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4817 Sniper(abl)-38
Specific and Nongenetic IAP-dependent Protein Eraser (SNIPER), acting as a protein degradation inducer of oncogenic BCR-ABL protein
More description
DCC4816 Snap-5089
Highly selective alpha1A-adrenoceptor antagonist
More description
DCC4815 Snap-398299
Potent and selective GAL3 antagonist
More description
DCC4814 Sn-38 Prodrug 3c
Novel Bioorthogonal Prodrug of SN-38 with Fast Reaction Kinetics and High Releasing Efficiency In Vivo
More description
DCC4813 Sn34037
Novel specific inhibitor of Aldo-keto reductase 1C3 (AKR1C3, EC 1.1.1.188)
More description
DCC4812 Sn-28049
Novel potent DNA-binding topoisomerase II-directed antitumor agent.
More description
DCC4811 Sn16713
Selective ligand of GC-rich sequences in DNA
More description
DCC4809 Smurf1 Inhibitor 1
Novel Smurf1 inhibitor, promoting bone formation in mouse models of distinctive age-related osteoporosis
More description
DCC4808 Smtp-7
Novel dual inhibitor of thrombolysis and soluble epoxide hydrolase
More description
DCC4807 Smt022357
Second-generation modulator of utrophin, increasing utrophin expression in skeletal, respiratory and cardiac muscles
More description
DCC4806 Smn-c5
Novel specific splicing enhancer, targeting RNA for a specific splicing correction, recognizing the interface between U1 snRNP and the SMN2 E7 5ʹ SS, promoting the U1-C zinc finger RNA duplex binding activity
More description
DCC4805 Smn2-stablizer-27
Novel Stablizer of Survival of Motor Neuron 2 (SMN2) , Post-Translationally Stablizing SMN Protein for the Treatment of Spinal Muscular Atrophy (SMA)
More description
DCC4804 Sml-8-73-1
Novel Active Site Inhibitor of Oncogenic K-Ras G12C
More description
DCC4803 Sml-10-70-1
Selective, direct-acting covalent inhibitor of the K-Ras G12C mutant relative to wild-type Ras
More description
DCC4802 Smk-17
Novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor
More description
DCC4801 Smip2.1
Novel TLR2 agonist, promoting cross-presentation by mouse and human antigen presenting cells
More description
DCC4800 smip001
Novel enhancer of the cyclin-dependent kinase (CDK) inhibitor p27(Kip)
More description
DCC4799 S-mgb-234 Bis-tfa Salt
Novel strathclyde minor groove binder (S-MGB), curing animal African trypanosomiasis (AAT)
More description
DCC4798 Smer10
Novel enhancer of the clearance of mutant aggregate-prone proteins by autophagy in mammalian cell models of Huntington's and Parkinson's disease, independent of rapamycin
More description
DCC4797 Smdc818909
Novel Allosteric Inhibitor of p97
More description
DCC4796 Smcy 5.5
Fluorogenic fluorescent probe for imaging lipid droplets; suitable for use with two-photon microscopy
More description
DCC4795 Smases D Inhibitor-5
Novel inhibitor of Loxosceles sphingomyelinases D (SMases D)
More description
DCC4794 Smases D Inhibitor-1
Novel inhibitor of Loxosceles sphingomyelinases D (SMases D)
More description
DCC4793 Smart-oh
Potent inhibitor of microtubule polymerization
More description
DCC4792 Smart-h
Potent inhibitor of microtubule polymerization
More description
DCC4791 Smapp1
Novel activator of PP1, inducing HIV-1 transcription, reactivation of latent HIV-1 in chronically infected cells, and CDK9 phosphorylation
More description
DCC4790 Smac127
Proapoptotic and anti-inflammatory agent, inducing apoptosis by inhibiting apoptosis proteins (IAPs)
More description
DCC4789 Sma-12b
Novel inhibitor of IL-1
More description
DCC4788 Sm4487
Novel potent and selective inhibitor of galactokinase (GALK1)
More description
DCC4787 Sm-337
Non-peptidic Smac mimetic, binding to XIAP, cIAP-1 and cIAP-2 proteins with higher affinities in cell growth inhibition in the MDA-MB-231 cell line
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X